COVID-19 UPDATE: Multiple reasons J&J vaccine "pause" not a recovery setback. Epicenter stocks significantly underperformed since mid-March, but EPS revisions = good and Technicals, while damaged, are still positive

Click HERE to access the FSInsight COVID-19 Daily Chartbook.

We are shifting to a 4-day a week publication schedule:

  • Monday
  • Tuesday
  • Wednesday
  • SKIP THURSDAY
  • Friday

STRATEGY:  Equities yesterday show "fire, ready, aim" still default reaction in pandemic
Global markets were roiled yesterday by the FDA's announcement to "pause" the J&J vaccine, out of an abundance of caution stemming from a rare blood clot side effect detected in 6 women administered the J&J COVID-19 vaccine.  This is a pretty serious blood clot called Cerebral Venous Sinus Thrombosis and is a type of stroke (Hopkins article on CVST).  

- overall, the media and news coverage of yesterday's events were very useful to me

But I was surprised that Street analyst commentary seemed to focus on explaining the mechanisms of how the drug might contribute to clotting, but provided little context whether these incidences are outside of normal chances, and also whether COVID-19 side effects itself were worse.

The video in this report is only accessible to members
Source: https://www.nytimes.com/2021/04/13/health/blood-clots-johnson-vaccine.html...Equities went full "stay at home" yesterday, selling Epicenter stocks againGiven the prospect for a delay in vaccine deployment, plus added fear by those "vaccine scared" and just general uncertainty around COVID-19, ...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free